Loxapine Succinate

Known as: 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine Succinate(1:1), Loxapinsuccinate, Butanedioic Acid, compound with 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine(1:1) 
The succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent with antiemetic, sedative, anticholinergic, and antiadrenergic… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1980
Review
1980
138 acutely ill schizophrenic patients were treated with oral loxapine succinate for up to 4 weeks in nine studies, all of which… Expand
Is this relevant?
1979
1979
1. A g.l.c. method for quantitative determination of loxapine (2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine), in… Expand
Is this relevant?
1978
1978
The intramuscular and oral forms of loxapine succinate were compared in their clinical, side effect, and blood level… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
1977
1977
In a double-blind, placebo controlled design in chronic schizophrenic inpatients using 50 mg. and 100 mg. LOX, an attempt was… Expand
Is this relevant?
1976
1976
A study was conducted evaluating the efficacy of loxapine succinate in newly admitted schizophrenic patients through a four-week… Expand
Is this relevant?
1976
1976
 
Is this relevant?
1976
1976
Thirty-one chronic psychotic patients were treated with loxapine succinate, 20 for two years and eleven for one year, in order to… Expand
Is this relevant?
1975
1975
Therapeutic efficacy and safety of loxapine succinate (LOX) and trifluoperazine hydrochloride were compared by means of a… Expand
Is this relevant?
1975
1975
Loxapine succinate was compared to chlorpromazine in a 12-week double-blind study of 50 hospitalized chronic schizophrenic… Expand
Is this relevant?